Topics:

Multiple sclerosis

Multiple sclerosis

Here: succinct highlights from new studies may offer you insights about multiple sclerosis you didn't have before.

Out of the blizzard of recently published clinical studies on multiple sclerosis, we've randomly selected 2 with useful information you might not want to -- but easily could -- miss. Here: brief synopses and links.

PRES

An unusual cause of postpartum neurologic deficits: MRIs of progressing relapsing-remitting MS; Lhermitte-Duclos disease as a cause of ataxia: here. . . 5 short clinical cases, each with images, that offer take-home messages you can use in your practice.

How do we use Tysabri responsibly? How often should you screen patients taking the medication for the JC virus? What are the considerations for transitioning JC+ patients to another medication--and when is the best time to make the transition?

A new study puts a final nail in the coffin for the hypothesis that chronic cerebrospinal venous insufficiency is neither specific or causative for multiple sclerosis.

In this study, high-dose simvastatin reduced the annualized rate of whole-brain atrophy in secondary progressive MS.

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.